Castle Biosciences Inc (CSTL): Next-Year EPS Estimate 35.99%
As of 2026-06-11, Castle Biosciences Inc (CSTL) has a next-year EPS growth estimate of 35.99%.
On 2026-05-31, analyst consensus for CSTL's next-year EPS growth shifted from 36.83% to 35.99% — a negative change of 0.84 percentage points. The revised estimate has been sustained across 10 subsequent trading sessions. Current-year growth is projected at -75.05%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- EPS growth next year
- 35.99%
- EPS growth this year
- -75.05%
- EPS next quarter (est)
- -$0.40
- Last price
- $21.01
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 35.99% | -75.05% | -$0.40 | $21.01 |
| 2026-06-10 | 35.99% | -75.05% | -$0.40 | $21.08 |
| 2026-06-09 | 35.99% | -75.05% | -$0.40 | $21.08 |
| 2026-06-08 | 35.99% | -75.05% | -$0.40 | $20.12 |
| 2026-06-07 | 35.99% | -75.05% | -$0.40 | $21.01 |
| 2026-06-04 | 35.99% | -75.05% | -$0.40 | $21.60 |
| 2026-06-03 | 35.99% | -75.05% | -$0.40 | $20.39 |
| 2026-06-02 | 35.99% | -75.05% | -$0.40 | $19.71 |
| 2026-06-01 | 35.99% | -75.05% | -$0.40 | $20.97 |
| 2026-05-31 | 35.99% | -75.05% | -$0.40 | $21.08 |
| 2026-05-28 | 36.83% | -71.88% | -$0.40 | $22.11 |
| 2026-05-27 | 36.83% | -71.88% | -$0.40 | $21.26 |
| 2026-05-26 | 36.83% | -71.88% | -$0.40 | $19.69 |
| 2026-05-25 | 36.83% | -71.88% | -$0.40 | $20.15 |
| 2026-05-24 | 36.83% | -71.88% | -$0.40 | $20.15 |
| 2026-05-21 | 36.83% | -71.88% | -$0.40 | $20.54 |
| 2026-05-20 | 36.83% | -71.88% | -$0.40 | $20.03 |
| 2026-05-19 | 36.83% | -71.88% | -$0.40 | $19.20 |
| 2026-05-18 | 36.83% | -71.88% | -$0.40 | $19.32 |
| 2026-05-17 | 36.83% | -71.88% | -$0.40 | $19.13 |
| 2026-05-14 | 36.83% | -71.88% | -$0.40 | $18.88 |
| 2026-05-13 | 36.83% | -71.88% | -$0.40 | $18.11 |
| 2026-05-12 | 39.79% | -61.60% | -$0.37 | $18.63 |
| 2026-05-11 | 39.79% | -61.60% | -$0.37 | $19.04 |
| 2026-05-10 | 39.79% | -61.60% | -$0.37 | $19.83 |
| 2026-05-07 | 39.80% | -61.65% | -$0.37 | $19.24 |
| 2026-05-06 | 53.41% | -41.27% | -$0.49 | $24.75 |
| 2026-05-05 | 53.41% | -41.27% | -$0.49 | $24.60 |
| 2026-05-04 | 53.41% | -41.27% | -$0.49 | $25.52 |
| 2026-05-03 | 53.41% | -41.27% | -$0.49 | $24.81 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Castle Biosciences Inc's next-year EPS growth estimate?▾
As of 2026-06-11, Castle Biosciences Inc (CSTL) has a next-year EPS growth estimate of 35.99%, based on analyst consensus.
When was the latest EPS estimate revision for CSTL?▾
The most recent revision occurred on 2026-05-31, when analysts adjusted the next-year EPS growth estimate from 36.83% to 35.99%.
What sector and industry does Castle Biosciences Inc belong to?▾
Castle Biosciences Inc operates in the Healthcare sector, specifically the Diagnostics & Research industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. CSTL appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Castle Biosciences Inc (CSTL) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports